Features Navigation

(800) 825-0224 Live Demo
ID Measure Name
006 Coronary Artery Disease (CAD): Antiplatelet Therapy
014 Age-Related Macular Degeneration (AMD): Dilated Macular Examination
021 Perioperative Care: Selection of Prophylactic Antibiotic – First OR
Second Generation Cephalosporin
023 Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When
Indicated in ALL Patients)
024 Communication with the Physician or Other Clinician Managing Ongoing Care Post-Fracture for Men and Women Aged 50 Years and Older
039 Screening for Osteoporosis for Women Aged 65-85 Years of Age
044 Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery
046 Medication Reconciliation Post-Discharge
047 Care Plan
048 Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
052 Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled
Bronchodilator Therapy
067 Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
068 Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy
069 Hematology: Multiple Myeloma: Treatment with Bisphosphonates
070 Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry
091 Acute Otitis Externa (AOE): Topical Therapy
093 Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance
of Inappropriate Use
104 Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer
116 Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis – National Quality Strategy Domain: Efficiency and Cost Reduction
118 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)
126 Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy
127 Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear
131 Pain Assessment and Follow-Up
137 Melanoma: Continuity of Care – Recall System
141 Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular
Pressure (IOP) by 15% OR Documentation of a Plan of Care
144 Oncology: Medical and Radiation – Plan of Care for Pain
146 Radiology: Inappropriate Use of “Probably Benign” Assessment Category
in Screening Mammograms
154 Falls: Risk Assessment
155 Falls: Plan of Care
164 Coronary Artery Bypass Graft (CABG): Prolonged Intubation
165 Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate
166 Coronary Artery Bypass Graft (CABG): Stroke
167 Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure
168 Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration
182 Functional Outcome Assessment
185 Colonoscopy Interval for Patients with a History of Adenomatous Polyps
– Avoidance of Inappropriate Use
195 Radiology: Stenosis Measurement in Carotid Imaging Reports
205 HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis
217 Functional Status Change for Patients with Knee Impairments
218 Functional Status Change for Patients with Hip Impairments
219 Functional Status Change for Patients with Foot or Ankle Impairments
220 Functional Status Change for Patients with Lumbar Impairments
221 Functional Status Change for Patients with Shoulder Impairments
222 Functional Status Change for Patients with Elbow, Wrist or Hand Impairments
223 Functional Status Change for Patients with General Orthopaedic Impairments
225 Radiology: Reminder System for Screening Mammograms
243 Cardiac Rehabilitation Patient Referral from an Outpatient Setting
249 Barrett’s Esophagus
250 Radical Prostatectomy Pathology Reporting
254 Ultrasound Determination of Pregnancy Location for Pregnant Patients with
Abdominal Pain
268 Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy
303 Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery
320 Appropriate Follow-Up Interval for Normal Colonoscopy in Average
Risk Patients
326 Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
328 Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dL
338 HIV Viral Load Suppression
340 HIV Medical Visit Frequency
345 Rate of Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) Who Are Stroke Free or Discharged Alive
346 Rate of Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA) Who Are Stroke Free or Discharged Alive
347 Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Who Are Discharged Alive
383 Adherence to Antipsychotic Medications For Individuals with Schizophrenia
392 Cardiac Tamponade and or Pericardiocentesis Following Atrial Fibrillation Ablation
394 Immunizations for Adolescents
411 Depression Remission at Six Months
417 Rate of Open Repair of Small or Moderate Abdominal Aortic Aneurysms (AAA) Where Patients Are Discharged Alive
418 Osteoporosis Management in Women Who Had a Fracture
422 Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury
424 Perioperative Temperature Management
431 Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
442 Persistence of Beta-Blocker Treatment After a Heart Attack
444 Medication Management for People with Asthma
445 Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)
446 Operative Mortality Stratified by the Five STS-EACTS Mortality Categories
448 Appropriate Workup Prior to Endometrial Ablation
449 HER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted Therapies
450 Trastuzumab Received By Patients With AJCC Stage I (T1c) – III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy
451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) 4 with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
453 Proportion Receiving Chemotherapy in the Last 14 Days of Life
454 Proportion of Patients who Died from Cancer with more than One Emergency Department Visit in the Last 30 Days of Life
455 Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life
456 Proportion Not Admitted To Hospice
457 Proportion Admitted to Hospice for less than 3 days

“The best thing I ever did in private practice was getting AdvancedMD—it has liberated me.”

Estaban Lavato, MD
La Loma Medical Center

“Other companies made their offers, but they required so much more money up front, I’ve seen a lot of different systems in my 18 years in billing. If you are looking for an easy-to-learn, cost-effective solution, AdvancedMD is your answer.”

Gloria Johnson
Billing manager

“The nice thing about AdvancedMD is claims are cleared before they are forwarded to various insurance companies. We know very, very quickly if we have some defective portion on our claim.”

Dwight Romriell, DMD

Read the story  ›

“Our workflow has diminished as far as the redundancies, having to do the back-and-click here or check on this and check on that—it’s all right there!”

Johnette Lamborne
Office manager